Stocksigma LogoStocksigma Logo

RPG Life Sciences to Acquire Raghava's API Business for Rs 135 Crores

RPG Life Sciences’ subsidiary, RPG Active Pharma, will acquire Raghava Life Sciences' API and intermediates business via slump sale for a cash

RPG Life Sciences to Acquire Raghava's API Business for Rs 135 Crores

RPG Life Sciences Ltd · Others (Uncategorized) · 03 Sept 2026, 3:48 am

RPG Life Sciences to Acquire Raghava's API Business for Rs 135 Crores RPG Life Sciences’ subsidiary, RPG Active Pharma, will acquire Raghava Life Sciences' API and intermediates business via slump sale for a cash consideration up to Rs 135 crores. The acquired business generated unaudited FY26 revenues of Rs 19 crores and includes manufacturing and R&D facilities, alongside 29 API molecules (22 commercialized). Expected to close within 30 days from 2nd Sep'26, the deal strategically expands RPG's API operations. Raghava's CRO and CRAMS divisions are explicitly excluded from this transaction.

Original exchange filing (PDF)

More announcements from RPG Life Sciences Ltd

All RPG Life Sciences Ltd announcements